LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer

被引:0
作者
Li-yuan Feng
Yong-zhi Huang
Wei Zhang
Li Li
机构
[1] Guangxi Medical University Cancer Hospital,Department of Gynecologic Oncology
[2] Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,undefined
[3] Ministry of Education,undefined
来源
Journal of Ovarian Research | / 14卷
关键词
Ovarian cancer; Chemoresistance ; LAMA3 methylation; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 110 条
[1]  
Lheureux S(2019)Epithelial ovarian cancer [J] Lancet 393 1240-1253
[2]  
Gourley C(2018)Ovarian Cancer Prevention and Screening [J] Obstet Gynecol 131 909-927
[3]  
Vergote I(2018)Diagnosis and Treatment of Ovarian Cancer [J] Hematol Oncol Clin North Am 32 943-964
[4]  
Menon U(2018)Molecular mechanisms of drug resistance in ovarian cancer [J] J Cell Physiol 233 4546-4562
[5]  
Karpinskyj C(2019)PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms [J] J Cell Mol Med 23 2303-2313
[6]  
Gentry-Maharaj A(2018)Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment [J] Endocr Relat Cancer 25 R303-R318
[7]  
Orr B(2017)Acquired chemotherapy resistance in ovarian cancer [J] Ann Oncol 28 viii13-viii15
[8]  
Edwards RP(2018)Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer [J] Hematol Oncol Clin North Am 32 983-996
[9]  
Norouzi-Barough L(2019)The roles of DNA, RNA and histone methylation in ageing and cancer [J] Nat Rev Mol Cell Biol 20 573-589
[10]  
Sarookhani MR(2013)DNA methylation and its basic function [J] Neuropsychopharmacology 38 23-38